Evaluating the bioactive effects of flavonoid hesperidin - A new literature data survey;Ocena bioaktivnih efekata flavonoida hesperidina - Pregled podataka iz novije literature

Vojnosanitetski Pregled

Volumn 71, Issue 1, 2014, Pages 60-65

  Kuntić, Vesna ^a   Brborić, Jasmina ^a   Holclajtner Antunović, Ivanka ^a   Uskoković Marković, Snežana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Antioxidants; Cardiovascular diseases; Hesperidin; Preventive health service; Radiation protective agents

Indexed keywords

CHOLESTEROL; DAFLON; HESPERIDIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; NUTRACEUTICAL; ROSE HIPS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CELL DEATH; CITRUS FRUIT; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG STRUCTURE; GENOTOXICITY; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; NONHUMAN; OXIDATIVE STRESS; RADIATION PROTECTION;

CARDIOVASCULAR DISEASES; HESPERIDIN; HUMANS; MORBIDITY; PRIMARY PREVENTION; WORLD HEALTH;

EID: 84893415105     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1401060K     Document Type: Article

References (76)

1. Pekal A., Drózdz P, Biesaga M, Pyrzynska K. Screening of the antioxidant properties and polyphenol composition of aromatised green tea infusions. J Sci Food Agric 2012; 92(11): 2244-9.
2. Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French Paradox Revisited. Front Pharmacol 2012; 3: 141.
3. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, et al. Flovonoid intake and cardiovascular disease wortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007; 85(3): 895-909.
4. Buijsse B, Weikert C, Drogan D, Bergmann M, Boeing H. Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults. Eur Heart J 2010; 31(13): 1616-123.
5. Auclair S, Milenkovic D, Besson C, Chauvet S, Gueux E, Morand C, et al. Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study. Atherosclerosis 2009; 204(2): e21-7.
6. Norata GD, Marchesi P, Passamonti S, Pirillo A, Violi F, Catapano AL. Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis 2007; 191(2): 265-71.
7. Lippi G, Franchini M, Favaloro EJ, Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the French paradox. Semin Thromb Hemost 2010; 36(1): 59-70.
8. Tapas AR, Sakarkar DM, Kakde RB. Flavonoids as Nutraceuticals: A Review. Trop J Pharm Res 2008; 7(3): 1089-99.
9. Melešev D, Kuntić V. Investigation of metal-flavonoid chelates and the determination of flavonoids via metal-flavonoid complexing reactions. J Serb Chem Soc 2007; 72(10): 921-39.
10. Andersen OM, Markham KR. Flavonoids: Chemistry, Biochemistry and Applications. Boca Raton, FL: CRC/Taylor & Francis; 2006.
11. Bentsath A, Rusznyak S, Szent-Györgyi A. Vitamin nature of flavones. Nature 1936; 138: 798.
12. Middleton EJ, Kandaswami C. The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer. In: Harborne JB, editor. The flavonoids: Advances in research since 1986. London: Chapman and Hall; 2005. pp. 619-52.
13. Cushnie TP, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Agent 2005; 26(5): 343-56.
14. Dalgård C, Nielsen F, Morrow JD, Enghusen-Poulsen H, Jonung T, Hørder M, et al. Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease. Br J Nutr 2009; 101(2): 263-9.
15. Middleton E, Kandaswami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem Pharmacol 1992; 43(6): 1167-1179.
16. Tanaka T, Makita H, Kawabata K, Mori H. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 1997; 18(5): 957-65.
17. Lee JH, Kim YS, Lee CK, Lee HK, Han SS. Antiviral activity of some flavonoids on Herpes-simplex virus. Korean Pharmacog 1999; 30: 34-9.
18. Neuhouser ML. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 2004; 50(1): 1-7.
19. Ren W, Qiao Z, Wang H, Zhu L, Zhang L. Flavonoids: promising anticancer agents. Med Res Rev 2003; 23(4): 519-34.
20. Bouskela E, Donyo KA. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/ reperfusion in diabetic hamsters. Int J Microcirc Clin Exp 1995; 15(6): 293-300.
21. McGregor L, Bellangeon M, Chignier E, Lerond L, Rousselle C, McGregor JL. Effect of a micronized purified flavonoid fraction on in vivo platelet functions in the rat. Thromb Res 1999; 94(4): 235-40.
22. Huxley RR, Neil HA. The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr 2003; 57(8): 904-8.
23. Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 1997; 349(9053): 699.
24. Grassi D, Desideri G, Croce G, Tiberti S, Aggio A, Ferri C. Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des 2009; 15(10): 1072-84.
25. Manach C, Regerat F, Texier O, Agullo G, Demigne C, Remesy C, et al. Bioavailability, metabolism and physiologic impact of 4- oxo-flavonoids. Nutr Res 1996; 16(3): 517-44.
26. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci 1993; 90(17): 7915-22.
27. Procházková D, Boušová I, Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia 2011; 82(4): 513-23.
28. Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc Trans 1894; 65: 889-910.
29. Van Acker VS, van Balen GP, van der Berg DJ, van der Vijgh WJ. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol 1998; 56(8): 935-43.
30. Afanas'ev IB, Dorozhko AI, Brodskii AV, Kostyuk VA, Potapovitch AI. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 1989; 38(11): 1763-9.
31. 2+ ions: implications for their antioxidant properties. Biochem J 1998; 330(Pt 3): 1173-8.
32. Fiorani M, De Sanctis R, De Bellis R, Dacha M. Intracellular flavonoids as electron donors for extracellular ferricyanide reduction in human erythrocytes. Free Radic Biol Med 2002; 32(1): 64-72.
33. Tajmir-Riahi HA, Diamantoglou S, Kanakis CD, Tarantilis PA, Polissiou MG. 2007. Flavonoids interactions with DNA and RNA: binding modes and antioxidative effects Acta Hort. (ISHS); 744: 195-204.
34. Mira L, Fernandez MT, Santos M, Rocha R, Florêncio MH, Jennings KR. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 2002; 36(11): 1199-208.
35. Kostyuk VA, Potapovich AI, Vladykovskaya EN, Korkina LG, Afanase'ev IB. Influence of metal ions on flavonoid protection against asbestos-induced cell injury. Arch Biochem Biophys 2001; 385(1): 129-37.
36. Moridani MY, Pourahmad J, Bui H, Siraki A, O'Brien PJ. Dietary flavonoid iron complexes as cytoprotective superoxide radical scavengers. Free Radic Biol Med 2003; 34(2): 243-53.
37. De Souza RF, De Giovani WF. Antioxidant properties of complexes of flavonoids with metal ions. Redox Rep 2004; 9(2): 97-104.
38. Afanas' IB, Ostrakhovitch EA, Mikhal'chik EV, Ibragimova GA, Korkina LG. Enhancement of antioxidant and antiinflammatory activities of bioflavonoid rutin by complexation with transition metals. Biochem Pharmacol 2001; 61(6): 677-84.
39. Barthe GA, Jourdan PS, Mclntosh CA, Mansell RL. Radioimmunossay for the quantitative determination of hesperidin and analysis of its distribution in Citrus sinensis. Phytochemistry 1988; 27(1): 249-54.
40. Leuzzi U, Caristi C, Panzera V, Licandro G. Flavonoids in pigmented orange juice and second-pressure extracts. J Agric Food Chem 2000; 48(11): 5501-6.
41. AIJN - European Fruit Juice Association. What is the AIJN Code of Practice? Available from: http://www.aijn.org/pages/cop/cop.html
42. Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Rémésy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 2003; 57(2): 235-42.
43. Malešev D, Radović Z, Kuntić V, Kosanić M. Spectrophotometric determination of hesperidin by Al(III)-hesperidin complex in water-methanol solution. Anal Letters 1997; 30(5): 917-26.
44. Kuntić V, Kosanić M, Malešev D, Radović Z, Mioč U. Spectrophotometric investigation of uranil(II)-hesperidin complex in 70% methanol. J Serb Chem Soc 1998; 63(7): 565-72.
45. Kuntić V, Blagojević S, Malešev D, Radović Z. Spectrophotometric investigation of Cu(II)-hesperidin complex in 50% ethanol. Pharmazie 1999; 54(7): 548-9.
46. Kuntić V, Filipović I, Vujić Z. Effects of rutin and hesperidin and their Al(III) and Cu(II) Complexes on in Vitro Plasma Coagulation Assays. Molecules 2011; 16(2): 1378-88.
47. Deng W, Fang X, Wu J. Flavonoids function as anti-oxidants: by scavenging reactive oxygen species or by chelating iron? Radiat Phys Chem 1997; 50(3): 271-6.
48. Suarez J, Herrera MD, Marhuenda E. In vitro scavenger and antioxidant properties of hesperidin and neohesperidin dihydrochalcone. Phytomedicine 1998; 5(6): 469-473.
49. Jovanovic SV, Steenken S, Tosic M, Marjanovic B, Simic MG. Flavonoids as anti-oxidants. J Am Chem Soc 1994; 116(11): 4846-51.
50. Bonina F, Lanza M, Montenegro L, Puglisi C, Tomaino A, Trombetta D, et al. Flavonoids as potential protective agents against photooxidative skin damage. Int J Pharm 1996; 145(1-2): 87-94.
51. Nandakumar N, Balasubramanian MP. Hesperidin a citrus bioflavonoid modulates hepatic biotransformation enzymes and enhances intrinsic antioxidants in experimental breast cancer rats challenged with 7, 12-dimethylbenz (a) anthracene. J Exp Ther Oncol 2012; 9(4): 321-35.
52. Hou M, Man M, Man W, Zhu W, Hupe M, Park K, et al. Topical hesperidin improves epidermal permeability barrier function and epidermal differentiation in normal murine skin. Exp Dermatol 2012; 21(5): 337-40.
53. Garg A, Garg S, Zaneveld LJD, Singla AK. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 2001; 15(8): 655-69.
54. Johnsen SP, Overvad K, Stripp C, Tjonneland A, Husted SE, Sorensen HT. Intake of fruit and vegetables and the risk of ischemic stroke in a cohort of Danish men and women. Am J Clin Nutr 2003; 78(1): 57-64.
55. Dauchet L, Ferrieres J, Arveiler D, Yarnell JW, Gey F, Ducimetiere P, et al. Frequency of fruit and vegetable consumption and coronary heart disease in France and Northern Ireland: the PRIME study. Br J Nutr 2004; 92(6): 963-72.
56. Guarnieri S, Riso P, Porrini M. Orange juice vs vitamin C: effect on hydrogen peroxide-induced DNA damage in mononuclear blood cells. Br J Nutr 2007; 97(4): 639-43.
57. Johnston CS, Dancho CL, Strong GM. Orange juice ingestion and supplemental vitamin C are equally effective at reducing plasma lipid peroxidation in healthy adult women. J Am Coll Nutr 2003; 22(6): 519-23.
58. Ghanim H, Sia CL, Upadhyay M, Korzeniewski K, Viswanathan P, Abuaysheh S, et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr 2010; 91(4): 940-9.
59. Sanchez-Moreno C, Cano MP, de Ancos B, Plaza L, Olmedilla B, Granado F, et al. Effect of orange juice intake on vitamin C concentrations and biomarkers of antioxidant status in humans. Am J Clin Nutr 2003; 78(3): 454-60.
60. Kurowska EM, Spence JD, Jordan J, Wetmore S, Freeman DJ, Piché LA, et al. HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr 2000; 72(5): 1095-100.
61. Reshef N, Hayari Y, Goren C, Boaz M, Madar Z, Knobler H. Antihypertensive effect of sweetie fruit in patients with stage I hypertension. Am J Hypertens 2005; 18(10): 1360-3.
62. Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A, et al. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 2011; 93(1): 73-80.
63. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008; 88(1): 38-50.
64. Demonty I, Lin Y, Zebregs YE, Vermeer MA, van der Knaap HC, Jakel M, et al. The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. J Nutr 2010; 140(9): 1615-20.
65. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 2003; 189(1-2): 1-20.
66. Mates JM, Sanchez-Jimenez FM. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol 2000; 32(2): 157-70.
67. Nambiar D, Rajamani P, Singh RP. Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy. Mutat Res 2011; 728(3): 139-57.
68. Hosseinimehr SJ. Trends in the development of radioprotective agents. Drug Discov Today 2007; 12(19-20): 794-805.
69. Van Acker FA, Schouten O, Haenen RM, van der Vijh WJ, Bast A. Flavanoid can replace tocopherol as an antioxidant. FEBS Lett 2000; 473(2): 145-8.
70. Hosseinimehr SJ, Nemati A. Radioprotective effects of hesperidin against gamma irradiation in mouse bone marrow cells. Br J Radiol 2006; 79(941): 415-8.
71. Pradeep K, Park SH, Ko KC. Hesperidin a flavanoglycone protects against γ-irradiation induced hepatocellular damage and oxidative stress in Sprague-Dawley rats. Eur J Pharmacol 2008; 587(1-3): 273-80.
72. Kalpana KB, Devipriya N, Srinivasan M, Vishwanathan P, Thayalan K, Menon VP. Evaluating the radioprotective effect of hesperidin in the liver of Swiss albino mice. Eur J Pharmacol 2011; 658(2-3): 206-12.
73. Hosseinimehr SJ, Ahmadi A, Mahmoudzadeh A, Mohamadifar S. Radioprotective effects of Daflon against genotoxicity induced by gamma irradiation in human cultured lymphocytes. Environ Mol Mutagen 2009; 50(9): 749-52.
74. Hosseinimehr SJ, Mahmoudzadeh A, Ahmadi A, Mohamadifar S, Akhlaghpoor S. Radioprotective effects of hesperidin against genotoxicity induced by γ-irradiation in human lymphocytes. Mutagenesis 2009; 24(3): 233-5.
75. Kalpana KB, Devipriya N, Srinivasan M, Menon VP. Investigation of the radioprotective efficacy of hesperidin against gammaradiation induced cellular damage in cultured human peripheral blood lymphocytes. Mutat Res 2009; 676(1-2): 54-61.
76. Kuntić V, Pejić N, Mićić S. Direct spectrophotometric determination of hesperidin in pharmaceutical preparations. Acta Chim Slov 2012; 59(2): 436-41.